Prospective Evaluation of the Optimal SCS Trial Length
ConditionSpinal Cord Stimulation
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOhio State University
About this trial
This study aims to determine the ideal length of a spinal cord stimulation (SCS) trial period by analyzing daily pain scores, patient satisfaction, and when patients decide whether to proceed with permanent implantation. The primary goal is to identify the shortest trial duration that can reliably predict SCS success. A secondary goal is to compare SCS trial outcomes with patient-reported health measures (PROMIS domains) and recommendations from the SCS E-Health Tool to evaluate how well these tools predict treatment candidacy and outcomes.
Eligibility criteria
Qualifiers
Adults aged 18 years or older who are able to provide informed consent.
Individuals with a clinical diagnosis of a chronic pain condition deemed appropriate for spinal cord stimulation (SCS) therapy by the treating physician.
Individuals with a documented duration of chronic pain greater than 12 weeks.
Individuals scheduled to undergo a spinal cord stimulation trial as part of routine clinical care at a participating site.
Disqualifiers
Pregnant individuals.
Individuals currently receiving or involved in a worker's compensation claim related to their pain condition.
Individuals with a history of a previously failed spinal cord stimulation (SCS) trial.
Individuals with chronic opioid use exceeding 50 morphine milligram equivalents (MME) per day.
Trial design
Treatments tested in this trial
- Spinal Cord Stimulation (SCS) Trial
Treatment groups
42 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov